B-cell targeted therapies show durable immune responses in pemphigus vulgaris and myasthenia gravis
New data shows how B-cell therapies treat autoimmune diseases
This systematic review of 24 clinical trials involving more than 3,500 participants evaluates B-cell targeted therapies for various autoimmu…
New research highlights how targeting specific immune cells can provide lasting relief for several different autoimmune conditions.
Switching therapy after rituximab resistance in AQP4-IgG+ NMOSD shows variable relapse outcomes
New Hope for Tough-to-Treat Nerve Disorder
This single-center, retrospective case series of 10 adults with AQP4-IgG+ NMOSD who were resistant to rituximab evaluated switching therapy.
Patients with a rare nerve disease who stopped responding to standard treatment found relief after switching to new therapies that prevented…